Envista Holdings Corp
NVST
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $4.4B
$27.28
▼ -1.12%
P/E
46.24
Mkt Cap
$4.4B
52-Wk Range
$18.77–$30.42
52-Week Range
$18.77 - $30.42
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 29.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive product portfolio across implants, orthodontics, and equipment reduces customer switching costs
- Proprietary digital software and imaging technology creates recurring revenue and customer lock-in
- Established distribution network and strong relationships with dental professionals globally
- Significant scale and manufacturing expertise in specialized dental products
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising global demand for dental procedures due to aging populations and increased healthcare awareness
Value
Attractively priced below sector peer average
Momentum
Strong
+16.4% over 3m
Quality
Strong
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying NVST right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of $0.41 vs $0.34 consensus (+22.3% surprise). Revenue of $730.5M vs $716.1M expected (+2.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+22.3%
Revenue trend · last 8Q
—
—
—
+8%
+11%
+15%
+14%
+7%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$601.0M
$652.9M
$616.9M
$682.1M
$669.9M
$750.6M
$705.5M
$730.5M
Margins · last 8Q
Gross
55.7%
Operating
11.0%
Profit
7.3%
Wall Street consensus
6 analysts · 33% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
33%
Hold
67%
Sell
0%
Median Price Target
—
Latest: Piper Sandler · Jul 29, 2026
vs Industry
How NVST stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.